Your browser doesn't support javascript.
loading
Everolimus, an mTORC1/2 inhibitor, in ART-suppressed individuals who received solid organ transplantation: A prospective study.
Henrich, Timothy J; Schreiner, Corinna; Cameron, Cheryl; Hogan, Louise E; Richardson, Brian; Rutishauser, Rachel L; Deitchman, Amelia N; Chu, Simon; Rogers, Rodney; Thanh, Cassandra; Gibson, Erica A; Zarinsefat, Arya; Bakkour, Sonia; Aweeka, Francesca; Busch, Michael P; Liegler, Teri; Baker, Christopher; Milush, Jeffrey; Deeks, Steven G; Stock, Peter G.
  • Henrich TJ; Division of Experimental Medicine, University of California San Francisco, San Francisco, California, USA.
  • Schreiner C; Division of Experimental Medicine, University of California San Francisco, San Francisco, California, USA.
  • Cameron C; Institute of Biochemistry and Molecular Biology, Ulm University, Ulm, Germany.
  • Hogan LE; Department of Nutrition, Case Western Reserve University, Cleveland, Ohio, USA.
  • Richardson B; Division of Experimental Medicine, University of California San Francisco, San Francisco, California, USA.
  • Rutishauser RL; Department of Nutrition, Case Western Reserve University, Cleveland, Ohio, USA.
  • Deitchman AN; Division of Experimental Medicine, University of California San Francisco, San Francisco, California, USA.
  • Chu S; Department of Clinical Pharmacy, University of California San Francisco, San Francisco, California, USA.
  • Rogers R; Department of Surgery, University of California San Francisco, San Francisco, California, USA.
  • Thanh C; Department of Surgery, University of California San Francisco, San Francisco, California, USA.
  • Gibson EA; Division of Experimental Medicine, University of California San Francisco, San Francisco, California, USA.
  • Zarinsefat A; Division of Experimental Medicine, University of California San Francisco, San Francisco, California, USA.
  • Bakkour S; Department of Surgery, University of California San Francisco, San Francisco, California, USA.
  • Aweeka F; Vitalant Research Institute, San Francisco, California, USA.
  • Busch MP; Department of Clinical Pharmacy, University of California San Francisco, San Francisco, California, USA.
  • Liegler T; Vitalant Research Institute, San Francisco, California, USA.
  • Baker C; Division of HIV, Infectious Diseases & Global Medicine, University of California San Francisco, San Francisco, California, USA.
  • Milush J; Division of HIV, Infectious Diseases & Global Medicine, University of California San Francisco, San Francisco, California, USA.
  • Deeks SG; Division of HIV, Infectious Diseases & Global Medicine, University of California San Francisco, San Francisco, California, USA.
  • Stock PG; Division of HIV, Infectious Diseases & Global Medicine, University of California San Francisco, San Francisco, California, USA.
Am J Transplant ; 21(5): 1765-1779, 2021 05.
Article en En | MEDLINE | ID: mdl-32780519
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Trasplante de Órganos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / Trasplante de Órganos Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Humans Idioma: En Año: 2021 Tipo del documento: Article